BRAF and melanoma: Several other quadruplex ligands have been previously reported as having activity in chemo-resistant cell lines44–47, for example substituted naphthalene diimide-based in patient-derived gastrointestinal cancer cells44 and in BRAF-mutant melanoma cells45.